Brief: Bionaturis receives EU grant to develop cervical cancer vaccines

Biotechnology Assets SA

09/12/2015 17:04

Dec 9 (Reuters) - Bioorganic Research and Services 
(Bionaturis) SA  BNT.MC : 
    * Receives subvention of 184,847.40 euros ($202,999) from 
European Union for its Cervi Pro initiative 
    * To work on cost-effective cervical cancer vaccine 
 
     
Source text: http://bit.ly/1SOlOZ7 
     
Further company coverage:  BNT.MC  
 
($1 = 0.9106 euros) 
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))